Document Detail


Surfactant biology and clinical application.
MedLine Citation:
PMID:  12848315     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
There is strong evidence that alterations in the pulmonary surfactant system play an important role in the pathophysiology of lung disease, including ARDS . Although it is still unclear whether mortality and morbidity of ARDS will be reduced, surfactant replacement therapy has been shown to improve oxygenation, improve lung compliance, and decrease the need for ventilatory support. The critical need for more standardized studies with one type of intratracheal surfactant and uniform measurements of surfactant proteins and phospholipids by BAL is evident. Further studies will also be needed to elucidate the optimal timing and dosage regimen for different disease processes. Some evidence supports the measurements of surfactant protein levels as markers for predicting the onset and outcome of ARDS and perhaps providing a window for early treatment of patients at risk to develop ARDS. Continued investigation into the role of surfactant in the immune regulation of the lung may also provide additional information to support the efficacy of surfactant replacement in lung disease.
Authors:
Sue E Poynter; Ann Marie LeVine
Related Documents :
8087335 - Fiber burden and patterns of asbestos-related disease in workers with heavy mixed amosi...
10949875 - How can ultrafine particles be responsible for increased mortality?
11834675 - Inhibition of human neutrophil elastase-induced acute lung injury in hamsters by recomb...
6604645 - The immotile-cilia syndrome compared to other obstructive lung diseases: a clue to thei...
1613735 - Proteinases in rheumatoid arthritis.
11829715 - Antihistamines in late-phase clinical development for allergic disease.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review    
Journal Detail:
Title:  Critical care clinics     Volume:  19     ISSN:  0749-0704     ISO Abbreviation:  Crit Care Clin     Publication Date:  2003 Jul 
Date Detail:
Created Date:  2003-07-09     Completed Date:  2003-08-05     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  8507720     Medline TA:  Crit Care Clin     Country:  United States    
Other Details:
Languages:  eng     Pagination:  459-72     Citation Subset:  IM    
Affiliation:
Division of Critical Care Medicine, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Humans
Lung Diseases / drug therapy*,  physiopathology*
Pediatrics*
Pulmonary Surfactants / chemistry,  pharmacology*,  therapeutic use*
Grant Support
ID/Acronym/Agency:
K12-HD00850/HD/NICHD NIH HHS; KO8 HL-03905/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Pulmonary Surfactants

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Coagulation dysfunction in sepsis and multiple organ system failure.
Next Document:  Pediatric intensive care unit nosocomial infections: epidemiology, sources and solutions.